Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha

Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha

US Patent 12240840 · Granted Mar 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted bicyclic heteroaryl compounds2025
Substituted carbazole compounds2025
Substituted carbazole compounds2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2025
Indazole carboxamides as kinase inhibitors2025
Substituted benzimidazolone compounds2025
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RI2024
Substituted indole and indazole compounds2024
Substituted indole and indazole compounds2024
Aminotriazolopyridines as kinase inhibitors2024
Aminotriazolopyridines as kinase inhibitors2024
Aminotriazolopyridines as kinase inhibitors2024